Dear Readers, It is time to think about the next chapter of The Trip Report. I have decided to take a hiatus from the 2-3 posts/week schedule that we'v…
Zach Haigney
Psychedelic News Roundup In Partnership with Lucid News Policy Can Psychedelics Help Save America? A Healthcare and bioethics group at Harvard Law scho…
Zach Haigney
There’s a tactic agreement that safety and efficacy are not going to be the barrier to rolling out psychedelic medicine— but rather, delivery will prov…
Zach Haigney
Field Trip IPO On Tuesday, Field Trip Psychedelics became the third publicly traded psychedelic company with at least a $100 million valuation behind M…
Zach Haigney
Jaguar makes one of the two FDA approved Botanical Drugs
Zach Haigney
On November 3rd Oregon voters will have the chance to vote for Measure 109, a state-regulated psilocybin therapy framework. It is the first state-level…
Zach Haigney
Numinus & Field Trip: A Tale of Two Strategies Announcements from Numinus and Field Trip highlight two different approaches and two different challenge…
Zach Haigney
With COMPASS Pathways' listing and early success on NASDAQ, a clear precedent is set. The premise of psychedelic medicine has been accepted by more ext…
Zach Haigney
Psychedelic Business News Roundup In Partnership with Lucid News UC Berkeley Center for the Science of Psychedelics “To the psychologist, the religious…
Zach Haigney
If psychedelics and their potential for healing and personal transformation weren't compelling enough, this re-emergence/renaissance is happening again…
Zach Haigney
There are mile markers along the highway to medicalization and the mainstream that are obvious and notable like Breakthrough Therapy Designation, filin…
Zach Haigney
Psychedelic Business News Roundup In Partnership with Lucid News Starting today, Wednesday’s Trip Report and psychedelic business news round-up will be…
Zach Haigney